Literature DB >> 35446622

Schwann cell necroptosis in diabetic neuropathy.

Alexia Belavgeni1,2, Francesca Maremonti1,2, Marlena Stadtmüller3, Stefan R Bornstein1,3,4,5,6,7, Andreas Linkermann1,2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35446622      PMCID： PMC9170031          DOI： 10.1073/pnas.2204049119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   12.779


× No keyword cloud information.
  38 in total

1.  Insights into the evolution of divergent nucleotide-binding mechanisms among pseudokinases revealed by crystal structures of human and mouse MLKL.

Authors:  James M Murphy; Isabelle S Lucet; Joanne M Hildebrand; Maria C Tanzer; Samuel N Young; Pooja Sharma; Guillaume Lessene; Warren S Alexander; Jeffrey J Babon; John Silke; Peter E Czabotar
Journal:  Biochem J       Date:  2014-02-01       Impact factor: 3.857

2.  Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis.

Authors:  Jie Zhao; Siriporn Jitkaew; Zhenyu Cai; Swati Choksi; Qiuning Li; Ji Luo; Zheng-Gang Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

3.  DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA.

Authors:  Jason W Upton; William J Kaiser; Edward S Mocarski
Journal:  Cell Host Microbe       Date:  2012-03-15       Impact factor: 21.023

4.  The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.

Authors:  James M Murphy; Peter E Czabotar; Joanne M Hildebrand; Isabelle S Lucet; Jian-Guo Zhang; Silvia Alvarez-Diaz; Rowena Lewis; Najoua Lalaoui; Donald Metcalf; Andrew I Webb; Samuel N Young; Leila N Varghese; Gillian M Tannahill; Esme C Hatchell; Ian J Majewski; Toru Okamoto; Renwick C J Dobson; Douglas J Hilton; Jeffrey J Babon; Nicos A Nicola; Andreas Strasser; John Silke; Warren S Alexander
Journal:  Immunity       Date:  2013-09-05       Impact factor: 31.745

Review 5.  Diabetic neuropathy.

Authors:  Eva L Feldman; Brian C Callaghan; Rodica Pop-Busui; Douglas W Zochodne; Douglas E Wright; David L Bennett; Vera Bril; James W Russell; Vijay Viswanathan
Journal:  Nat Rev Dis Primers       Date:  2019-06-13       Impact factor: 52.329

6.  DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB.

Authors:  Manuele Rebsamen; Leonhard X Heinz; Etienne Meylan; Marie-Cécile Michallet; Kate Schroder; Kay Hofmann; Jessica Vazquez; Chris A Benedict; Jürg Tschopp
Journal:  EMBO Rep       Date:  2009-07-10       Impact factor: 8.807

7.  RGMb protects against acute kidney injury by inhibiting tubular cell necroptosis via an MLKL-dependent mechanism.

Authors:  Wenjing Liu; Binbin Chen; Yang Wang; Chenling Meng; Huihui Huang; Xiao-Ru Huang; Jinzhong Qin; Shrikant R Mulay; Hans-Joachim Anders; Andong Qiu; Baoxue Yang; Gordon J Freeman; Hua Jenny Lu; Herbert Y Lin; Zhi-Hua Zheng; Hui-Yao Lan; Yu Huang; Yin Xia
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-30       Impact factor: 11.205

8.  Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.

Authors:  Sudan He; Lai Wang; Lin Miao; Tao Wang; Fenghe Du; Liping Zhao; Xiaodong Wang
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

9.  Targeting RIPK1 for the treatment of human diseases.

Authors:  Alexei Degterev; Dimitry Ofengeim; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-02       Impact factor: 11.205

10.  A novel neurodegenerative spectrum disorder in patients with MLKL deficiency.

Authors:  Soren L Faergeman; Hayley Evans; Kathrine E Attfield; Christiane Desel; Subita Balaram Kuttikkatte; Mette Sommerlund; Lise Torp Jensen; Jorgen Frokiaer; Manuel A Friese; Paul M Matthews; Christian Luchtenborg; Britta Brügger; Annette Bang Oturai; Calliope A Dendrou; Lars Fugger
Journal:  Cell Death Dis       Date:  2020-05-01       Impact factor: 8.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.